Frontiers and Hotspots of Adipose Tissue and NAFLD: a Bibliometric Analysis from 2002 to 2022

Overview

Journal Front Physiol

Date 2024 Jan 8

PMID 38187139

Authors

Shuxiao Gu

Yanfang Qiao

Susu Liu

Shuangjie Yang

Shibo Cong

Sili Wang

Deshuai Yu

Wei Wang

Xinlou Chai

Affiliations

Soon will be listed here.

Abstract

The annual incidence of non-alcoholic fatty liver disease (NAFLD) continues to rise steadily. In recent years, adipose tissue (AT) has gained recognition as a pivotal contributor to the pathogenesis of NAFLD. Employing bibliometric analysis, we examined literature concerning AT and NAFLD. Relevant literature on AT in NAFLD from 1980 to 2022 was extracted from the Web of Science Core Collection. These records were visualized using CiteSpace and VOSviewer regarding publications, countries/regions, institutions, authors, journals, references, and keywords. Since 2002, a total of 3,330 papers have been included, exhibiting an annual surge in publications. Notably, the quality of publications is superior in the USA and Europe. Kenneth Cusi stands out as the author with the highest number of publications and H-index. is the journal boasting the highest citation and H-index. The University of California System holds the highest centrality among institutions. References specifically delve into physiological processes associated with AT in NAFLD. Currently, lipid metabolism and inflammation constitute the principal research mechanisms in the AT-based regulation of NAFLD, with pertinent keywords including microRNA, T cell, hypoxia, sarcopenia, hepatokine, gut microbiota, and autophagy. The Mediterranean diet is among the most widely recommended dietary approaches for potential NAFLD treatment. This paper represents the inaugural bibliometric study on the effects of AT on NAFLD, offering valuable insights and directions for future research.

Citing Articles

The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency.

Tattoli I, Mathew A, Verrienti A, Pallotta L, Severi C, Andreola F Cells. 2024; 13(19.

PMID: 39404394 PMC: 11475612. DOI: 10.3390/cells13191631.

Common Bean Suppresses Hepatic Ceramide Metabolism in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Fitzgerald V, Lutsiv T, McGinley J, Neil E, Playdon M, Thompson H Nutrients. 2024; 16(18).

PMID: 39339796 PMC: 11434909. DOI: 10.3390/nu16183196.

Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study.

Zyoud S, Hegazi O, Alalalmeh S, Shakhshir M, Abushamma F, Khilfeh S World J Hepatol. 2024; 16(6):951-965.

PMID: 38948442 PMC: 11212647. DOI: 10.4254/wjh.v16.i6.951.

Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis.

Tudor M, Gheorman V, Simeanu G, Dobrinescu A, Padureanu V, Dinescu V Metabolites. 2024; 14(4).

PMID: 38668326 PMC: 11052048. DOI: 10.3390/metabo14040198.

References

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

Tilg H, Moschen A . Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010; 52(5):1836-46. DOI: 10.1002/hep.24001. View

Zambon Azevedo V, Silaghi C, Maurel T, Silaghi H, Ratziu V, Pais R . Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr. 2022; 8:774030. PMC: 8802760. DOI: 10.3389/fnut.2021.774030. View

Muzurovic E, Mikhailidis D, Mantzoros C . Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021; 119:154770. DOI: 10.1016/j.metabol.2021.154770. View

Tong J, Li D, Meng H, Sun D, Lan X, Ni M . Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease. Acta Pharm Sin B. 2022; 12(9):3650-3666. PMC: 9513461. DOI: 10.1016/j.apsb.2022.02.003. View

Alisi A, Bedogni G, De Vito R, Comparcola D, Manco M, Nobili V . Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. Dig Liver Dis. 2010; 43(2):143-6. DOI: 10.1016/j.dld.2010.05.007. View

Chen C . Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004; 101 Suppl 1:5303-10. PMC: 387312. DOI: 10.1073/pnas.0307513100. View

du Plessis J, van Pelt J, Korf H, Mathieu C, Van der Schueren B, Lannoo M . Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(3):635-48.e14. DOI: 10.1053/j.gastro.2015.05.044. View

Ko M, Yun J, Baek I, Jang J, Hwang J, Lee S . Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice. Autophagy. 2020; 17(5):1205-1221. PMC: 8143238. DOI: 10.1080/15548627.2020.1753002. View

10.

van den Hoek A, de Jong J, Worms N, van Nieuwkoop A, Voskuilen M, Menke A . Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk. Metabolism. 2021; 124:154873. DOI: 10.1016/j.metabol.2021.154873. View

11.

Polyzos S, Kountouras J, Mantzoros C . Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2014; 64(1):60-78. DOI: 10.1016/j.metabol.2014.10.012. View

12.

Halberg N, Wernstedt-Asterholm I, Scherer P . The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008; 37(3):753-68, x-xi. PMC: 2659415. DOI: 10.1016/j.ecl.2008.07.002. View

13.

Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenwalder M, Tacke F . Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J Hepatol. 2022; 77(4):1136-1160. DOI: 10.1016/j.jhep.2022.06.012. View

14.

Younossi Z, Baranova A, Stepanova M, Page S, Calvert V, Afendy A . Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. J Proteome Res. 2010; 9(6):3218-24. DOI: 10.1021/pr100069e. View

15.

Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M . Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010; 464(7293):1313-9. DOI: 10.1038/nature08991. View

16.

Li Y, Luan Y, Li J, Song H, Li Y, Qi H . Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism. Hepatol Int. 2020; 14(6):1057-1074. DOI: 10.1007/s12072-020-10096-0. View

17.

Park Y, Myers M, Vieira-Potter V . Adipose tissue inflammation and metabolic dysfunction: role of exercise. Mo Med. 2014; 111(1):65-72. PMC: 6179510. View

18.

Shen W, Middleton M, M Cunha G, Delgado T, Wolfson T, Gamst A . Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. J Hepatol. 2022; 78(2):238-246. PMC: 9852022. DOI: 10.1016/j.jhep.2022.10.027. View

19.

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

20.

Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O . Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes. 2011; 60(10):2484-95. PMC: 3178277. DOI: 10.2337/db11-0174. View